share_log

Altimmune | 4: Statement of changes in beneficial ownership of securities-Officer Roberts M Scot

Altimmune | 4: Statement of changes in beneficial ownership of securities-Officer Roberts M Scot

Altimmune | 4:持股變動聲明-高管 Roberts M Scot
美股SEC公告 ·  08/01 17:46
Moomoo AI 已提取核心訊息
On July 31, 2024, Altimmune, Inc.'s Chief Scientific Officer, M Scot Roberts, completed a purchase of 650 shares of common stock at a price of $5.41 per share. Following this transaction, Roberts directly holds a total of 43,310 shares in the company. Additionally, it was disclosed that Roberts has an indirect ownership of 15 shares held by his spouse. The transaction, which is part of the direct holdings of non-derivative securities, reflects a vested interest in the company's performance by one of its key executives.
On July 31, 2024, Altimmune, Inc.'s Chief Scientific Officer, M Scot Roberts, completed a purchase of 650 shares of common stock at a price of $5.41 per share. Following this transaction, Roberts directly holds a total of 43,310 shares in the company. Additionally, it was disclosed that Roberts has an indirect ownership of 15 shares held by his spouse. The transaction, which is part of the direct holdings of non-derivative securities, reflects a vested interest in the company's performance by one of its key executives.
2024年7月31日,Altimmune公司的首席科學官萬·斯科特·羅伯茨以每股5.41美元的價格購買了650股普通股。此次交易後,羅伯茨直接持有該公司43310股股份。此外,披露了羅伯茨的配偶持有15股間接所有權。這筆交易是非衍生證券的直接持股部分,反映出公司的核心高管之一對公司業績的投入。
2024年7月31日,Altimmune公司的首席科學官萬·斯科特·羅伯茨以每股5.41美元的價格購買了650股普通股。此次交易後,羅伯茨直接持有該公司43310股股份。此外,披露了羅伯茨的配偶持有15股間接所有權。這筆交易是非衍生證券的直接持股部分,反映出公司的核心高管之一對公司業績的投入。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息